Partial T cell activation with an altered superantigenic ligand

被引:4
作者
Hayball, JD [1 ]
Lake, RA [1 ]
机构
[1] Queen Elizabeth II Med Sch, Univ Dept Med, Nedlands, WA, Australia
关键词
altered peptide ligand; superantigen; T cell receptor; T lymphocyte;
D O I
10.1046/j.1440-1711.2000.00880.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T cells have the capacity to respond to ligands as full, weak, partial or null agonists, or indeed as antagonists. In the present paper, it is reported that staphylococcal enterotoxin B (SEB) mutated in a T cell receptor (TCR) contact site (SEB Delta 61Y) behaves as an altered ligand for a T cell clone (AC20) that expresses the V beta 17 TCR. The T cells were partially activated by SEB Delta 61Y, as shown by TCR down-modulation and up-regulation of the IL-2 receptor. However, these cells did not secrete IL-2, IL-3, IL-4 or IFN-gamma, nor did they proliferate. Analysis of intracellular protein tyrosine phosphorylation after cellular activation provided further evidence that SEB Delta 61Y could transduce a signal via the V beta 17 TCR. The events following receptor ligation were clearly different when the T cells were stimulated with SEE or SEB Delta 61Y, manifested as both quantitatively and qualitatively different patterns of phosphorylation of intracellular substrates. In contrast, only quantitative differences were apparent when a transfectant expressing the same alpha/beta TCR was stimulated with the different superantigens. Together, these results provide the first demonstration that altered TCR ligands are not restricted to peptides substituted at secondary TCR contact residues. Rather, an altered superantigenic ligand mutated in the TCR binding site can behave as a partial agonist.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 43 条
  • [1] Accommodation of vascularized xenografts: Expression of ''protective genes'' by donor endothelial cells in a host Th2 cytokine environment
    Bach, FH
    Ferran, C
    Hechenleitner, P
    Mark, W
    Koyamada, N
    Miyatake, T
    Winkler, H
    Badrichani, A
    Candinas, D
    Hancock, WW
    [J]. NATURE MEDICINE, 1997, 3 (02) : 196 - 204
  • [2] BUELOW R, 1992, J IMMUNOL, V148, P1
  • [3] BUSCH R, 1991, J IMMUNOL, V147, P1292
  • [4] Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands
    Combadiere, B
    Sousa, CRE
    Germain, RN
    Lenardo, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) : 349 - 355
  • [5] ANTIGEN ANALOG MAJOR HISTOCOMPATIBILITY COMPLEXES ACT AS ANTAGONISTS OF THE T-CELL RECEPTOR
    DEMAGISTRIS, MT
    ALEXANDER, J
    COGGESHALL, M
    ALTMAN, A
    GAETA, FCA
    GREY, HM
    SETTE, A
    [J]. CELL, 1992, 68 (04) : 625 - 634
  • [6] Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids
    Ding, YH
    Smith, KJ
    Garboczi, DN
    Utz, U
    Biddison, WE
    Wiley, DC
    [J]. IMMUNITY, 1998, 8 (04) : 403 - 411
  • [7] EVAVOLD BD, 1993, J IMMUNOL, V150, P3131
  • [8] SEPARATION OF IL-4 PRODUCTION FROM TH-CELL PROLIFERATION BY AN ALTERED T-CELL RECEPTOR LIGAND
    EVAVOLD, BD
    ALLEN, PM
    [J]. SCIENCE, 1991, 252 (5010) : 1308 - 1310
  • [9] TICKLING THE TCR - SELECTIVE T-CELL FUNCTIONS STIMULATED BY ALTERED PEPTIDE LIGANDS
    EVAVOLD, BD
    SLOANLANCASTER, J
    ALLEN, PM
    [J]. IMMUNOLOGY TODAY, 1993, 14 (12): : 602 - 609
  • [10] Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
    Garboczi, DN
    Ghosh, P
    Utz, U
    Fan, QR
    Biddison, WE
    Wiley, DC
    [J]. NATURE, 1996, 384 (6605) : 134 - 141